Previous Close | 0.6100 |
Open | 1.1000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 13.00 |
Expire Date | 2024-10-25 |
Day's Range | 0.6100 - 1.2600 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Novavax (NVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The Biden administration is making another round of four free at-home Covid-19 tests available each household that requests them, updated to better detect current strains of the virus as the number of infections and hospitalizations is surging. The tests can be ordered through the Covidtests.gov website, which is now open for business. Households can get four tests, and as in previous rounds, the tests will be mailed directly to people’s homes.
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.